Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/26/2001 | CN1328157A Efficient expression system of genetically engineered antibody eukaryon and its preparing process and application |
12/26/2001 | CN1328155A Polypeptide-human topoisomeras I 9.79 and polynucleotide for coding it |
12/26/2001 | CN1328154A Polypeptide-DNA topoisomerase II-beta (TOP2B)10.34 and polynucleotide for coding it |
12/26/2001 | CN1328153A Polypeptide-dihydroorotase 10 and polynucleotide for coding it |
12/26/2001 | CN1328151A Polypeptide-proteasome p 40.5 subunit 9.79 and polynucleotide for coding it |
12/26/2001 | CN1328149A Polypeptide-phosphodiesterase 10.12 and polynucleotide for coding it |
12/26/2001 | CN1328147A Polypeptide-human phosphatidase 49.06 and polynucleotide for coding it |
12/26/2001 | CN1328145A Human mannose transferase and its coding sequence |
12/26/2001 | CN1328142A Polypeptide-dihydropyrrole-5-carboxylate reductase 15 and polynucleotide for coding it |
12/26/2001 | CN1328141A Polypeptide-isopenicillin N synthase 31 and polynucleotide for coding it |
12/26/2001 | CN1328140A Polypeptide-citrate synthase 11.77 and polynucleotide for coding it |
12/26/2001 | CN1328139A Polypeptide-human 6-acetonylacyl tetrahydogen (biologic) pterin synthase (PTPS) 41.03 and polynucleotide for coding it |
12/26/2001 | CN1328138A Polypeptide-human RNA cyclase 12 and plynucleotide for coding it |
12/26/2001 | CN1328137A Polypeptide-human ubiquitin desmoenzyme 9.46 and polynucleotide for coding it |
12/26/2001 | CN1328134A Coding sequence of protein kinase, polypeptide coded by it and its preparing process and usage |
12/26/2001 | CN1328058A Polypeptide-human Maxi Potassiumion channel beta2 subunit 11.55 and polynucleotide for coding it |
12/26/2001 | CN1328056A Polypeptide-human zinc finger protein 10.56 and polynucleotide for coding it |
12/26/2001 | CN1328054A Polypeptide-human Homer associated protein 12.54 and polynucleotide for coding it |
12/26/2001 | CN1328052A Polypeptide-human myoglobulin 25.19 and polynucleotide for coding it |
12/26/2001 | CN1328048A Polypeptide-human I-type transcription growth factor beta receptor associated protein 9.57 and polynucleotide for coding it |
12/26/2001 | CN1328047A Polypeptide-human Karyopherin 3 protein 56.1 and polynucleotide for coding it |
12/26/2001 | CN1328046A Polypeptide-human zinc finger protein 24.97 and polynucleotide for coding it |
12/26/2001 | CN1328045A Polypeptide-human BAF 57 protein 11.55 and polynucleotide for coding it |
12/26/2001 | CN1328044A Polypeptide-human shear factor 22.55 and polynucleotide for coding it |
12/26/2001 | CN1328042A Polypeptide-human Parkinson syndrome associated protein 13.31 and polynucleotide for coding it |
12/26/2001 | CN1328041A Polypeptide-human Parkinson syndrome associated protein 13.2 and polynucleotide for coding it |
12/26/2001 | CN1328039A Polypeptide-human ribosomal protein L7all.77 and polynucleotide for coding it |
12/26/2001 | CN1328038A Polypeptide-human actin associated protein 13E-32 and polynucleotide for coding it |
12/26/2001 | CN1328037A Polypeptide-human mitochondrion ATP enzyme coupling factor F624.09 and polynucleotide for coding it |
12/26/2001 | CN1328036A Polypeptide-human p300/CBP binding factor 10.56 and polynucleotide for coding it |
12/26/2001 | CN1328035A Polypeptide-corticotrophin releasing factor 10 and polynucleotide for coding it |
12/26/2001 | CN1328034A Polypeptide-human zinc finger protein SAG protein 20.46 and polynucleotide for coding it |
12/26/2001 | CN1328033A Polypeptide-human Fe-S protein 9.46 and polynucleotide for coding it |
12/26/2001 | CN1328031A Polypeptide-human cobalamin bindin 10.45 and polynucleotide for coding it |
12/26/2001 | CN1328030A Polypeptide-human cancer suppressor gene 98 and polynucleotide for coding it |
12/26/2001 | CN1328028A Polypeptide-human inhibitory glycine receptor-postsynaptic nexin 15.4 and polynucleotide for coding it |
12/26/2001 | CN1328027A Polypeptide-human CAD protein 9.02 and polynucleotide for coding it |
12/26/2001 | CN1328026A Polypeptide-human genetical multi-effect regulator 1(PLRG1) protein 9.9 and polynucleotide for coding it |
12/26/2001 | CN1328025A Polypeptide-human replication start codon initiation recognition complex subunit Orc4Lp(HsORC4L) 12.21 and polynucleotide for coding it |
12/26/2001 | CN1328023A Polypeptide-human rap 55 mRNA bindin 19 and polynucleotide for coding it |
12/26/2001 | CN1328022A Polypeptide-human zinc finger protein 10.89 and polynucleotide for coding it |
12/26/2001 | CN1328021A Polypeptide-human wither inhibitor 38.06 and polynucleotide for coding it |
12/26/2001 | CN1328020A Polypeptide-human zinc finger protein 17.93 and polynucleotide for coding it |
12/26/2001 | CN1328019A Polypeptide-estrogen receptor associated protein 24.31 and polynucleotide for coding it |
12/26/2001 | CN1328018A Polypeptide-human TNFR/NGFR protein 10 containing cytochrome C structure domain and polynucleotide for coding it |
12/26/2001 | CN1328015A Polypeptide-human cell wither associated protein 14.52 and polynucleotide for coding it |
12/26/2001 | CN1328014A Polypeptide-TGF beta receptor associated protein 110.23 and polynucleotide for coding it |
12/26/2001 | CN1328013A Polypeptide-laminin B210.67 and polynucleotide for coding it |
12/26/2001 | CN1328010A Polypeptide-fibrinogen 11 and polynucleotide for coding it |
12/26/2001 | CN1328008A Polypeptide-cytochrome b5-10 and polynucleotide for coding it |
12/26/2001 | CN1328006A Polypeptide-cytochrome b5-13 and polynucleotide for coding it |
12/26/2001 | CN1328005A Polypeptide-cytochrome b5-9 and polynucleotide for coding it |
12/26/2001 | CN1328003A Polypeptide-G protein 9 and polynucleotide for coding it |
12/26/2001 | CN1328002A Polypeptide-ring finger gene MID 120.13 and polynucleotide for coding it |
12/26/2001 | CN1327999A Polypeptide-calcium ion bindin 14 and polynucleotide for coding it |
12/26/2001 | CN1327995A Polypeptide-replication initiation recognition complex subunit ORC413.64 and polynucleotide for coding it |
12/26/2001 | CN1327994A Polypeptide-cytoblast matrix p84 protein 39.27 and polynucleotide for coding it |
12/26/2001 | CN1327992A Polypeptide-estrogen receptor associated protein 8.91 and polynucleotide for coding it |
12/26/2001 | CN1327990A Polypeptide-transmembrane 4 protein 22 and polynucleotide for coding it |
12/26/2001 | CN1327989A Polypeptide-gamma carboxylglutamate protein 18.91 richly contained proline and polynucleotide for coding it |
12/26/2001 | CN1327988A Polypeptide-zinc finger protein 26.29 and polynucleotide for coding it |
12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
12/25/2001 | US6333407 Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
12/25/2001 | US6333405 Nucleotide sequences coding immunoglobulins for use in the treatment of cancer; anticarcinogenic agents |
12/25/2001 | US6333403 Nucleotide sequences coding polypeptide associated with tumors; for use in diagnosis and treatment of tumors |
12/25/2001 | US6333398 Protein purification |
12/25/2001 | US6333397 Hybridoma cell culture; for use in generation of preferential immunoglobulin which binds preferential muscle protein; for use in diagnosis of heart defects |
12/25/2001 | US6333396 Genetically engineered binding polypeptide; for use in cancer diagnosis and therapy; for use in gene therapy |
12/25/2001 | US6333359 Regulation of cellular apoptosis using modulators of β-AR receptors |
12/25/2001 | US6333312 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
12/25/2001 | US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis |
12/25/2001 | US6333162 Method for measuring cholinesterase and method for distinguishing between liver cirrhosis and hepatitis |
12/25/2001 | US6333161 Assaying a test ligands ability to bind a central nervous system receptor by incubation the ligand with mutant cells that produce a kainate-binding excitatory amino acid receptor and determining the extent of binding |
12/25/2001 | US6333035 Administering monoclonal antibody against a human t-cell leukemia virus-derived transcription activating factor p40tax-induced cell membrane glycoprotein of 34 kda (gp34) in an amount effective for treating rheumatoid arthritis |
12/25/2001 | US6333034 Administering anti-properdin agent effective to selectively inhibit formation of an alternative complement pathway activation product |
12/25/2001 | US6333033 Autoantibody inhibitors |
12/25/2001 | US6333032 Administering to antibody to gamma interferon in an amount effective to neutralize or reduce fluid activity levels of gamma interferon for therapy of multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis |
12/25/2001 | CA2094027C Osteogenic peptides |
12/25/2001 | CA1341328C Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
12/20/2001 | WO2001096601A2 Neurotransmission disorders |
12/20/2001 | WO2001096580A2 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
12/20/2001 | WO2001096574A1 Novel enzyme gene and its expression product |
12/20/2001 | WO2001096566A1 Gasc1 gene |
12/20/2001 | WO2001096563A1 Scramblase 2 |
12/20/2001 | WO2001096562A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
12/20/2001 | WO2001096557A2 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
12/20/2001 | WO2001096547A2 Human kinases |
12/20/2001 | WO2001096546A2 Protein phosphatases |
12/20/2001 | WO2001096528A2 Human tumor necrosis factor delta and epsilon |
12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
12/20/2001 | WO2001096401A1 METHOD OF CONSTRUCTING scFv ANTIBODY FUSED WITH FLUORESCENT PROTEIN |
12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
12/20/2001 | WO2001095938A1 Preventives/remedies for granuloma |
12/20/2001 | WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |